149 related articles for article (PubMed ID: 2971083)
1. Hypotensive effect of taurine. Possible involvement of the sympathetic nervous system and endogenous opiates.
Fujita T; Sato Y
J Clin Invest; 1988 Sep; 82(3):993-7. PubMed ID: 2971083
[TBL] [Abstract][Full Text] [Related]
2. The antihypertensive effect of taurine in DOCA-salt rats.
Fujita T; Sato Y
J Hypertens Suppl; 1984 Dec; 2(3):S563-5. PubMed ID: 6152784
[TBL] [Abstract][Full Text] [Related]
3. Hypotensive action of taurine in DOCA-salt rats--involvement of sympathoadrenal inhibition and endogenous opiate.
Sato Y; Ogata E; Fujita T
Jpn Circ J; 1991 May; 55(5):500-8. PubMed ID: 2062001
[TBL] [Abstract][Full Text] [Related]
4. Changes in cardiac and hypothalamic noradrenergic activity with taurine in DOCA-salt rats.
Fujita T; Sato Y; Ando K
Am J Physiol; 1986 Nov; 251(5 Pt 2):H926-33. PubMed ID: 2877584
[TBL] [Abstract][Full Text] [Related]
5. Role of sympathetic nervous system in hypotensive action of taurine in DOCA-salt rats.
Sato Y; Ando K; Fujita T
Hypertension; 1987 Jan; 9(1):81-7. PubMed ID: 2878880
[TBL] [Abstract][Full Text] [Related]
6. Influence of endogenous opiates on the hypotensive action of taurine in DOCA-salt rats.
Sato Y; Fujita T
J Hypertens Suppl; 1988 Dec; 6(4):S375-7. PubMed ID: 3241221
[TBL] [Abstract][Full Text] [Related]
7. [Antihypertensive action of K in rats with DOCA-salt-induced hypertension].
Sato Y; Fujita T; Yamashita K
Nihon Yakurigaku Zasshi; 1983 Aug; 82(2):117-30. PubMed ID: 6662415
[TBL] [Abstract][Full Text] [Related]
8. Changes in renal and central noradrenergic activity with potassium in DOCA-salt rats.
Fujita T; Sato Y
Am J Physiol; 1984 May; 246(5 Pt 2):F670-5. PubMed ID: 6144278
[TBL] [Abstract][Full Text] [Related]
9. Alterations in circulating levels and cardiovascular tissue content of neuropeptide Y-like immunoreactivity during the development of deoxycorticosterone acetate-salt hypertension in the rat.
Moreau P; de Champlain J; Yamaguchi N
J Hypertens; 1992 Aug; 10(8):773-80. PubMed ID: 1325509
[TBL] [Abstract][Full Text] [Related]
10. Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats.
Lee TM; Chen CC; Chang NC
Clin Sci (Lond); 2012 Oct; 123(7):445-57. PubMed ID: 22507072
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors.
Hirata Y; Suzuki Y; Suzuki E; Hayakawa H; Kimura K; Goto A; Omata M; Minamino N; Kangawa K; Matsuo H
J Hypertens; 1994 Apr; 12(4):367-74. PubMed ID: 8064160
[TBL] [Abstract][Full Text] [Related]
12. Changes in blood pressure and extracellular fluid with taurine in DOCA-salt rats.
Fujita T; Sato Y
Am J Physiol; 1986 Jun; 250(6 Pt 2):R1014-20. PubMed ID: 3717374
[TBL] [Abstract][Full Text] [Related]
13. Augmented vasodepressor and sympathetic responses to intracerebroventricular injections of diltiazem, a calcium channel blocker, in DOCA-salt hypertensive rats.
Takahashi H; Okabayashi H; Suga K; Iyoda I; Matsuzawa M; Ikegaki I; Yoshimura M; Ijichi H
J Hypertens Suppl; 1986 Dec; 4(6):S156-9. PubMed ID: 3475411
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
Ishii R; Tagawa T; Ishida T; Naruse T
Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
[TBL] [Abstract][Full Text] [Related]
15. Systemic and regional hemodynamic effect of acute magnesium administration in the normotensive and hypertensive state.
DiPette DJ; Simpson K; Guntupalli J
Magnesium; 1987; 6(3):136-49. PubMed ID: 3626625
[TBL] [Abstract][Full Text] [Related]
16. Retardation of the development of hypertension in DOCA salt rats by taurine supplement.
Inoue A; Takahashi H; Lee LC; Sasaki S; Kohno Y; Takeda K; Yoshimura M; Nakagawa M
Cardiovasc Res; 1988 May; 22(5):351-8. PubMed ID: 3191519
[TBL] [Abstract][Full Text] [Related]
17. Enhanced hypotensive effects of the essential oil of Ocimum gratissimum leaves and its main constituent, eugenol, in DOCA-salt hypertensive conscious rats.
Interaminense LF; Leal-Cardoso JH; Magalhães PJ; Duarte GP; Lahlou S
Planta Med; 2005 Apr; 71(4):376-8. PubMed ID: 15856420
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms.
Callera GE; Tostes RC; Yogi A; Montezano AC; Touyz RM
Clin Sci (Lond); 2006 Feb; 110(2):243-53. PubMed ID: 16271043
[TBL] [Abstract][Full Text] [Related]
19. Inverse blood pressure rhythm of transgenic hypertensive TGR(mREN2)27 rats: role of norepinephrine and expression of tyrosine-hydroxylase and reuptake1-transporter.
Lemmer B; Schiffer S; Witte K; Gorbey S
Chronobiol Int; 2005; 22(3):473-88. PubMed ID: 16076648
[TBL] [Abstract][Full Text] [Related]
20. Suppression of renal sympathetic activity with potassium supplement in DOCA-salt rats.
Sato Y; Fujita T
Jpn Heart J; 1984 Mar; 25(2):253-61. PubMed ID: 6748225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
